Founder of EIP Pharma, Inc., Sylvie Louise Grégoire is a Canadian businessperson who has been at the head of 6 different companies and presently is Executive Chairman at this company and Chairman of Corvidia Therapeutics, Inc.

She is also on the board of PerkinElmer, Inc. (United States), Novo Nordisk An and Shire Orphan Therapies GmbH.

In her past career she occupied the position of Chairman at Metriopharm AG, Executive Vice President-Business Development of Biogen, Inc. and Executive Vice President-Technical Operations at Biogen MA, Inc. (a subsidiary of Biogen, Inc.), Executive Chairman for IDM Pharma, Inc., President, CEO & Executive Director at GlycoFi, Inc., President at Shire Human Genetic Therapies, Inc. and President-Human Genetic Therapies Division at Shire Plc.

She received an undergraduate degree from Université Laval, a doctorate from State University of New York at Buffalo and an undergraduate degree from Séminaire de Sherbrooke.